AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Difficulty of the Sample Size Estimation
The number of non-COVID pulmonary infections, straps, pneumococcal, emophilus have gone markedly down. So that explains some of it. We also noticed that in another trial the Andromeda trial on a resuscitation protocol they too enrolled to relatively more patients with GI focus. The dynamics around this I cannot untangle them anymore but this is just I guess what happened.